Aktuellt
SENASTE
Redeye provides an initial take on SenzaGen’s H2 2022 report. We argue the year has been strong with total sales of SEK41.8m (SEK15.4m), which can be compared to our sales estimate of SEK46.6m. Even if the total sales were a bit lower than our full-year estimate, EBIT came in at SEK-25.1m (SEK-31.5m), which was better than our EBIT estimate of SEK-28.4m. We will provide an update shortly; however, we do not expect to make any major changes in our forecasts for the following years.
LÄS MER
